Rare Gastric Lesions Associated with Infection: A Histopathological Review
Helicobacter pylori infection is associated with chronic gastritis, peptic ulcer disease, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. However, some rare gastric lesions exhibiting distinctive histological features may also be associated with H. pylori infection, including...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology
2017-07-01
|
Series: | Journal of Pathology and Translational Medicine |
Subjects: | |
Online Access: | http://www.jpatholtm.org/upload/pdf/jptm-2017-04-03.pdf |
id |
doaj-e396b2ecfcd149798db29742b5d5a68d |
---|---|
record_format |
Article |
spelling |
doaj-e396b2ecfcd149798db29742b5d5a68d2020-11-24T22:43:13ZengKorean Society of Pathologists & the Korean Society for CytopathologyJournal of Pathology and Translational Medicine2383-78372383-78452017-07-0151434135110.4132/jptm.2017.04.0316693Rare Gastric Lesions Associated with Infection: A Histopathological ReviewMee JooHelicobacter pylori infection is associated with chronic gastritis, peptic ulcer disease, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. However, some rare gastric lesions exhibiting distinctive histological features may also be associated with H. pylori infection, including lymphocytic gastritis, granulomatous gastritis, Russell body gastritis, or crystal-storing histiocytosis. Although diverse factors can contribute to their development, there is convincing evidence that H. pylori infection may play a pathogenic role. These findings are mainly based on studies in patients with these lesions who exhibited clinical and histological improvements after H. pylori eradication therapy. Thus, H. pylori eradication therapy might be indicated in patients with no other underlying disease, particularly in countries with a high prevalence of H. pylori infection. This review describes the characteristic histological features of these rare lesions and evaluates the evidence regarding a causative role for H. pylori infection in their pathogenesis.http://www.jpatholtm.org/upload/pdf/jptm-2017-04-03.pdfStomachGastritisRareImmunoglobulins |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mee Joo |
spellingShingle |
Mee Joo Rare Gastric Lesions Associated with Infection: A Histopathological Review Journal of Pathology and Translational Medicine Stomach Gastritis Rare Immunoglobulins |
author_facet |
Mee Joo |
author_sort |
Mee Joo |
title |
Rare Gastric Lesions Associated with Infection: A Histopathological Review |
title_short |
Rare Gastric Lesions Associated with Infection: A Histopathological Review |
title_full |
Rare Gastric Lesions Associated with Infection: A Histopathological Review |
title_fullStr |
Rare Gastric Lesions Associated with Infection: A Histopathological Review |
title_full_unstemmed |
Rare Gastric Lesions Associated with Infection: A Histopathological Review |
title_sort |
rare gastric lesions associated with infection: a histopathological review |
publisher |
Korean Society of Pathologists & the Korean Society for Cytopathology |
series |
Journal of Pathology and Translational Medicine |
issn |
2383-7837 2383-7845 |
publishDate |
2017-07-01 |
description |
Helicobacter pylori infection is associated with chronic gastritis, peptic ulcer disease, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. However, some rare gastric lesions exhibiting distinctive histological features may also be associated with H. pylori infection, including lymphocytic gastritis, granulomatous gastritis, Russell body gastritis, or crystal-storing histiocytosis. Although diverse factors can contribute to their development, there is convincing evidence that H. pylori infection may play a pathogenic role. These findings are mainly based on studies in patients with these lesions who exhibited clinical and histological improvements after H. pylori eradication therapy. Thus, H. pylori eradication therapy might be indicated in patients with no other underlying disease, particularly in countries with a high prevalence of H. pylori infection. This review describes the characteristic histological features of these rare lesions and evaluates the evidence regarding a causative role for H. pylori infection in their pathogenesis. |
topic |
Stomach Gastritis Rare Immunoglobulins |
url |
http://www.jpatholtm.org/upload/pdf/jptm-2017-04-03.pdf |
work_keys_str_mv |
AT meejoo raregastriclesionsassociatedwithinfectionahistopathologicalreview |
_version_ |
1725696908757827584 |